Utility of novel serum biomarkers to predict subclinical atherosclerosis: A sub-analysis of the EISNER study

Certain novel biomarkers may predict atherosclerotic cardiovascular disease (ASCVD) events; however, data on their relationship to coronary atherosclerosis and its progression as measured by coronary artery calcium (CAC) scanning is lacking. We evaluated the association between novel biomarkers and presence or progression of CAC.
Source: Atherosclerosis - Category: Cardiology Authors: Source Type: research